Our NHS Commitments

Alpha Laboratories Ltd commits to reduce scope 1 and scope 2 GHG emissions 60% by 2034 from a 2022 base year, and to measure and reduce its scope 3 emissions. Alpha Laboratories Ltd commits to reach net-zero by 2045. As part of this, it commits to reduce scope 1, 2 and 3 emissions 95% by 2045 from a 2022 base year.

Alpha aligns its science-based net zero target to the NHS emissions reduction target ensuring no more than 5% of baseline Scope 1 and 2 emissions, and 10% of baseline Scope 3 emissions remain by 2045. All residual emissions (for those which cannot be reduced) will be offset and sequestered through a certified carbon offsetting programme.

We continue to work with our customers and suppliers to find innovative and sustainable solutions to help reduce NHS resources through the creation of a more efficient patient pathway.  

We are pleased to have completed the NHS Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in us receiving a Level 2: Comprehensive net zero targets and reporting for carbon emissions. The information reported through Evergreen is supporting us to understand our alignment with NHS sustainability priorities and identify those areas in which we need to accelerate progress.

The Evergreen Assessment is one of several NHS initiatives designed to support its net zero and wider sustainability objectives. We are delighted to be supporting the NHS to achieve their net zero and sustainability ambitions, including those set out in the NHS Net Zero Supplier Roadmap.